Segraves, R., T., M.D., Ph.D. Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2004
NCT00248209
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now